covered entities; 340B drugs; distribution

Arizona's HB 2965 prohibits drug manufacturers or their agents from restricting access to 340B drugs for qualified healthcare providers (like safety-net hospitals and clinics), or requiring extra data sharing beyond federal requirements. The bill bans actions such as denying drug deliveries, imposing unfair restrictions, or demanding unnecessary claims data as a condition for 340B drug access. Violations can be enforced by the state board or attorney general, with penalties per package. The law explicitly aligns with federal 340B program rules and does not override federal law or create private lawsuits.